Assyro AI

Orange Book product · Brand (NDA)

BEIZRAY

DOCETAXEL

Brand (NDA)NDA 218711RX ZHUHAI

At a glance

Oct 23, 2024

Approved

Brand (NDA)

Application

Not listed

TE code

11

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 23, 2024

    1 yr 8 mo ago

  2. Today

  3. Patent 11419842 expires

    Listed drug product patent expiration.

    May 16, 2036

    in 10 yr 1 mo

  4. Patent 11419842 expires

    Listed drug product patent expiration.

    May 16, 2036

    in 10 yr 1 mo

  5. Patent 11419842 expires

    Listed drug product patent expiration.

    May 16, 2036

    in 10 yr 1 mo

  6. Patent 11419842 expires

    Listed drug product patent expiration.

    May 16, 2036

    in 10 yr 1 mo

  7. Patent 11419842 expires

    Listed drug product patent expiration.

    May 16, 2036

    in 10 yr 1 mo

  8. Patent 12090134 expires

    Listed drug product patent expiration.

    May 16, 2036

    in 10 yr 1 mo

  9. Patent 12090134 expires

    Listed drug product patent expiration.

    May 16, 2036

    in 10 yr 1 mo

  10. Patent 12090134 expires

    Listed drug product patent expiration.

    May 16, 2036

    in 10 yr 1 mo

  11. Patent 12090134 expires

    Listed drug product patent expiration.

    May 16, 2036

    in 10 yr 1 mo

  12. Patent 12090134 expires

    Listed drug product patent expiration.

    May 16, 2036

    in 10 yr 1 mo

  13. Patent 12090135 expires

    Listed drug product patent expiration.

    May 16, 2036

    in 10 yr 1 mo

Pharmaceutical detail

Active ingredient

DOCETAXEL

Strength

80MG/4ML (20MG/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 218711

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (11)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11419842May 16, 2036in 10 yr 1 mo
ProductU-881
11419842May 16, 2036in 10 yr 1 mo
ProductU-937
11419842May 16, 2036in 10 yr 1 mo
ProductU-946
11419842May 16, 2036in 10 yr 1 mo
ProductU-4027
11419842May 16, 2036in 10 yr 1 mo
ProductU-4028
12090134May 16, 2036in 10 yr 1 mo
ProductU-881
12090134May 16, 2036in 10 yr 1 mo
ProductU-937
12090134May 16, 2036in 10 yr 1 mo
ProductU-946
12090134May 16, 2036in 10 yr 1 mo
ProductU-4027
12090134May 16, 2036in 10 yr 1 mo
ProductU-4028
12090135May 16, 2036in 10 yr 1 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.